Corbus Pharmaceuticals Holding Stock Market Value
| CRBP Stock | USD 7.71 0.04 0.52% |
| Symbol | Corbus |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Corbus Pharmaceuticals. If investors know Corbus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Corbus Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Corbus Pharmaceuticals is measured differently than its book value, which is the value of Corbus that is recorded on the company's balance sheet. Investors also form their own opinion of Corbus Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Corbus Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Corbus Pharmaceuticals' market value can be influenced by many factors that don't directly affect Corbus Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Corbus Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Corbus Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Corbus Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Corbus Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Corbus Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Corbus Pharmaceuticals.
| 07/09/2024 |
| 07/04/2025 |
If you would invest 0.00 in Corbus Pharmaceuticals on July 9, 2024 and sell it all today you would earn a total of 0.00 from holding Corbus Pharmaceuticals Holding or generate 0.0% return on investment in Corbus Pharmaceuticals over 360 days. Corbus Pharmaceuticals is related to or competes with McGrath RentCorp, Arbor Realty, Herc Holdings, GATX, AerCap Holdings, FTAI Aviation, and PennantPark Floating. Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for ... More
Corbus Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Corbus Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Corbus Pharmaceuticals Holding upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.92 | |||
| Information Ratio | 0.1122 | |||
| Maximum Drawdown | 28.76 | |||
| Value At Risk | (7.18) | |||
| Potential Upside | 10.46 |
Corbus Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Corbus Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Corbus Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Corbus Pharmaceuticals historical prices to predict the future Corbus Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.2244 | |||
| Jensen Alpha | 0.6095 | |||
| Total Risk Alpha | 0.3643 | |||
| Sortino Ratio | 0.1202 | |||
| Treynor Ratio | 0.8439 |
Corbus Pharmaceuticals Backtested Returns
Corbus Pharmaceuticals appears to be somewhat reliable, given 3 months investment horizon. Corbus Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.15, which signifies that the company had a 0.15 % return per unit of risk over the last 3 months. By analyzing Corbus Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.77% is justified by implied risk. Please makes use of Corbus Pharmaceuticals' Downside Deviation of 4.92, risk adjusted performance of 0.2244, and Mean Deviation of 4.08 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Corbus Pharmaceuticals holds a performance score of 11. The firm shows a Beta (market volatility) of 0.82, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Corbus Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Corbus Pharmaceuticals is expected to be smaller as well. Please check Corbus Pharmaceuticals' expected short fall, and the relationship between the maximum drawdown and rate of daily change , to make a quick decision on whether Corbus Pharmaceuticals' price patterns will revert.
Auto-correlation | 0.47 |
Average predictability
Corbus Pharmaceuticals Holding has average predictability. Overlapping area represents the amount of predictability between Corbus Pharmaceuticals time series from 9th of July 2024 to 5th of January 2025 and 5th of January 2025 to 4th of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Corbus Pharmaceuticals price movement. The serial correlation of 0.47 indicates that about 47.0% of current Corbus Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.47 | |
| Spearman Rank Test | 0.22 | |
| Residual Average | 0.0 | |
| Price Variance | 3.54 |
Corbus Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Corbus Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Corbus Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Corbus Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Corbus Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Corbus Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Corbus Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Corbus Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Corbus Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Corbus Pharmaceuticals Lagged Returns
When evaluating Corbus Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Corbus Pharmaceuticals stock have on its future price. Corbus Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Corbus Pharmaceuticals autocorrelation shows the relationship between Corbus Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Corbus Pharmaceuticals Holding.
Regressed Prices |
| Timeline |
Pair Trading with Corbus Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Corbus Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corbus Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Corbus Stock
Moving against Corbus Stock
| 0.82 | ACW | Actinogen Medical | PairCorr |
| 0.64 | BMY | Bristol Myers Squibb Sell-off Trend | PairCorr |
| 0.57 | SCLX | Scilex Holding | PairCorr |
| 0.56 | AVH | Avita Medical | PairCorr |
| 0.52 | OGN | Organon | PairCorr |
The ability to find closely correlated positions to Corbus Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Corbus Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Corbus Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Corbus Pharmaceuticals Holding to buy it.
The correlation of Corbus Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Corbus Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Corbus Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Corbus Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Corbus Stock Analysis
When running Corbus Pharmaceuticals' price analysis, check to measure Corbus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corbus Pharmaceuticals is operating at the current time. Most of Corbus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Corbus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corbus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Corbus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.